Literature DB >> 18211612

Prevalence and determinants of pharmacy shopping behaviour.

H Buurma1, M L Bouvy, P A G M De Smet, A Floor-Schreudering, H G M Leufkens, A C G Egberts.   

Abstract

BACKGROUND AND
OBJECTIVE: Discontinuity of care bears the risk of medication errors and poor clinical outcomes. Little is known about the continuity of care related to pharmacies. Therefore, we studied the prevalence and determinants of pharmacy shopping behaviour in the Netherlands.
METHODS: Beneficiaries from a Dutch pharmacy claims database who had visited two or more pharmacies in 2001 were indicated as 'shoppers' (n = 45 805). A random sample was taken from all the other beneficiaries who had received at least one prescription: 'non-shoppers' (n = 45 805). Shoppers were classified as light (all patients who visited more than one pharmacy at least once in 2001, except for patients defined as heavy or moderate shoppers), moderate (visited 3 or 4 pharmacies and had proportion of prescriptions elsewhere >10% and number of prescriptions elsewhere >10) or heavy (visited 5 or more pharmacies and had proportion of prescriptions elsewhere >10% and number of prescriptions elsewhere >10). Determinants of shopping behaviour were investigated as well as the association between any dispensing of Anatomical Therapeutic Chemical (ATC) classes of drugs and this behaviour.
RESULTS: 10.8% beneficiaries were identified as shoppers: 98.8%'light shoppers', 1.0%'moderate shoppers' and 0.2%'heavy shoppers'. Female gender [odds ratio (OR)(adj) 1.2; 95% confidence interval (CI) 1.1-1.2], younger age (OR(adj) 1.7; 95%CI 1.7-1.8), the use of > or =3 drugs (OR(adj) 2.9; 95%CI 2.8-3.0) and visiting different kind of prescribers (OR(adj) 2.4; 95%CI 2.4-2.5) were associated with shopping behaviour. Shoppers more frequently received at least one prescription for systemic anti-infectives (51.7% vs. 30.8%; OR 2.4; 95%Cl 2.3-2.5) and for nervous system drugs (46.2% vs. 29.3%; OR 2.1; 95%Cl 2.0-2.1).
CONCLUSIONS: Pharmacy shopping behaviour is limited in the Netherlands. However, it may put the patient at risk for unintentional problems, such as drug-drug interactions with anti-infectives. A small proportion of patients exhibit possibly intentional shopping behaviour with psychotropic drugs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18211612     DOI: 10.1111/j.1365-2710.2008.00878.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  48 in total

1.  Contraindicated use of 5-alpha-reductase inhibitors in women.

Authors:  Martina Teichert; Eugene van Puijenbroek; Bruno H Stricker
Journal:  Br J Clin Pharmacol       Date:  2016-09-30       Impact factor: 4.335

2.  Long term trends in oral antidiabetic drug use among children and adolescents in the Netherlands.

Authors:  S Fazeli Farsani; P C Souverein; J A Overbeek; M M J van der Vorst; C A J Knibbe; R M C Herings; A de Boer; A K Mantel-Teeuwisse
Journal:  Br J Clin Pharmacol       Date:  2015-05-20       Impact factor: 4.335

Review 3.  Comparison of delivery strategies for pharmacogenetic testing services.

Authors:  Susanne B Haga; Jivan Moaddeb
Journal:  Pharmacogenet Genomics       Date:  2014-03       Impact factor: 2.089

4.  Preventing hospital admissions by reviewing medication (PHARM) in primary care: design of the cluster randomised, controlled, multi-centre PHARM-study.

Authors:  Anne J Leendertse; Fred H P de Koning; Alex N Goudswaard; Andries R Jonkhoff; Sander C A van den Bogert; Han J de Gier; Toine C G Egberts; Patricia M L A van den Bemt
Journal:  BMC Health Serv Res       Date:  2011-01-07       Impact factor: 2.655

5.  The prevalence and incidence of medicinal cannabis on prescription in The Netherlands.

Authors:  Arno Hazekamp; Eibert R Heerdink
Journal:  Eur J Clin Pharmacol       Date:  2013-04-16       Impact factor: 2.953

6.  Medication reconciliation to solve discrepancies in discharge documents after discharge from the hospital.

Authors:  Marlies M E Geurts; Merel van der Flier; Anne M B de Vries-Bots; Thaliet I C Brink-van der Wal; Johan J de Gier
Journal:  Int J Clin Pharm       Date:  2013-04-18

7.  Association between ADHD drug use and injuries among children and adolescents.

Authors:  Els van den Ban; Patrick Souverein; Willemijn Meijer; Herman van Engeland; Hanna Swaab; Toine Egberts; Eibert Heerdink
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-06-04       Impact factor: 4.785

8.  Implementation of medication reviews in community pharmacies and their effect on potentially inappropriate drug use in elderly patients.

Authors:  Martina Teichert; Susan Noyon Luijben; Anouk Wereldsma; Ton Schalk; Jacqueline Janssen; Michel Wensing; Peter de Smet
Journal:  Int J Clin Pharm       Date:  2013-05-22

9.  Patients' understanding of the reasons for starting and discontinuing inhaled corticosteroids.

Authors:  Tanja T Menckeberg; Marcel L Bouvy; Madelon Bracke; Jacqueline G Hugtenburg; Jan-Willem Lammers; Jan A M Raaijmakers
Journal:  Br J Clin Pharmacol       Date:  2008-08       Impact factor: 4.335

10.  Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study.

Authors:  S Pouwels; T P van Staa; A C G Egberts; H G M Leufkens; C Cooper; F de Vries
Journal:  Osteoporos Int       Date:  2009-01-21       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.